Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polyps 2Hyperplasia 2Colorectal Neoplasms 2Weight Loss 1Psoriasis 1Osteoarthritis 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Breast Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Megestrol Acetate 6Standard of Care 3Exercise 3Physical Therapy Modalities 2Nutrition Assessment 2Infliximab 2Blood Specimen Collection 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1clazakizumab 1bermekimab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Preoperative Exercise 1Powders 1Pentoxifylline 1Olanzapine 1Nandrolone Decanoate 1Mirtazapine 1Melatonin 1Megestrol 1Immunologic Techniques 1Ibuprofen 1High-Energy Shock Waves 1Ghrelin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cachexia × Eicosapentaenoic Acid × Clear all
NCT00031707 2016-07-14

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Alliance for Clinical Trials in Oncology

Phase 3 Completed
429 enrolled

Anorexia, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡